JBT Marel Corporation, formed from the January 2025 combination of JBT and Marel, supplies food and beverage processing technology. Its quarterly results offer a window into capital spending by poultry, meat, seafood, and packaged food producers. The third quarter highlighted a core tension: the company is executing well on margins and cost synergies even as demand in its CPG end markets stays soft. For investors, the report matters because it tests whether merger-driven efficiency gains can offset uneven revenue growth and support the raised profitability targets management has emphasized since the deal closed. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
JBT Marel reported third quarter 2026 revenue of $994 million, down 1% from $1,001 million in the prior-year period and below the roughly $1.03 billion consensus. The shortfall stemmed mainly from lower book-and-ship volume in the Diversified Food and Health business, which serves consumer packaged goods customers.
Profitability came in stronger than the top line. Adjusted EPS reached $2.19, ahead of the $2.10 consensus and up 13% from $1.94 a year earlier. Adjusted EBITDA rose 5% to a record $179 million, equating to a record 18.0% margin. GAAP net income increased 6% to $70 million, a 7.0% net income margin, while GAAP diluted EPS was $1.34 compared with $1.26.
By segment, Protein Solutions revenue grew 6% to $469 million on poultry volume, with a 22.4% adjusted EBITDA margin. Prepared Food and Beverage Solutions revenue declined 6% to $525 million, though its margin improved to 19.2%. Quarter-end backlog stood at $1.52 billion, and inbound orders totaled $976 million. Year-to-date free cash flow was $252 million, up about $90 million year over year.
Management revised full-year 2026 revenue guidance to $3.95 billion–$4.0 billion, implying roughly 5% growth at the midpoint including a 1.5% foreign exchange benefit. It simultaneously raised the adjusted EBITDA margin outlook to 17.25%–17.5% and adjusted EPS guidance to $8.10–$8.40, with GAAP diluted EPS expected at $4.30–$4.60.
The earnings release drew a divided response from investors. The adjusted EPS beat, record margins, and raised profitability guidance signaled strong operational execution, while the revenue miss and lowered full-year sales outlook reflected persistent softness in CPG demand. This mix left sentiment focused on whether margin gains from cost synergies, pricing, and footprint optimization can keep compensating for slower revenue growth. The expanded $700 million buyback authorization and healthy free cash flow were seen as supportive signals, but investors weighed those positives against the trimmed top-line forecast and continued uncertainty in CPG-related end markets.
Looking ahead, investors should watch how JBT Marel’s demand environment evolves across its two segments. Management expects a seasonally stronger fourth quarter, helped by a robust poultry backlog and typical year-end food facility activity. Protein Solutions is positioned for continued growth, while the Prepared Food and Beverage Solutions segment faces ongoing headwinds from the Diversified Food and Health business.
Several factors will shape the next several quarters. Cost synergy realization, including labor productivity, supply chain savings, and facility consolidation, remains central to the company’s margin trajectory. Management indicated further footprint closures are planned through 2027, which should extend efficiency gains but require careful execution.
Other items to monitor include CPG capital spending trends, tariff and inflationary pressures, and free cash flow conversion. The company’s ability to balance share repurchases against a net leverage ratio of roughly 2.0 to 2.5 times will also be an important signal of financial flexibility. Backlog conversion and inbound order trends will offer early evidence of whether revenue growth can reaccelerate toward management’s mid-single-digit ambition.
I often turn to Tickeron’s AI Screener when reviewing earnings like these. It lets me quickly filter for comparable companies in the food processing space, spot technical patterns, and check how JBT Marel stacks up on fundamentals and volatility. The tool has become a regular part of my workflow for identifying setups and monitoring shifts in market conditions without spending hours on manual screens.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The Moving Average Convergence Divergence (MACD) for JBTM turned positive on October 09, 2026. Looking at past instances where JBTM's MACD turned positive, the stock continued to rise in 44 of 57 cases over the following month. The odds of a continued upward trend are 77%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where JBTM's RSI Indicator exited the oversold zone, 17 of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 63%.
The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on JBTM as a result. In 76 of 115 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 66%.
JBTM moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +4.02% 3-day Advance, the price is estimated to grow further. Considering data from situations where JBTM advanced for three days, in 183 of 275 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where JBTM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.
JBTM broke above its upper Bollinger Band on November 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for JBTM entered a downward trend on October 29, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating steady price growth. JBTM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 62 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.331) is normal, around the industry mean (4.069). P/E Ratio (31.106) is within average values for comparable stocks, (37.908). Projected Growth (PEG Ratio) (1.220) is also within normal values, averaging (1.879). Dividend Yield (0.003) settles around the average of (0.031) among similar stocks. P/S Ratio (1.481) is also within normal values, averaging (186.943).
The Tickeron PE Growth Rating for this company is 79 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 84 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. JBTM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of food processing and ground support equipment for the aviation industry
Industry IndustrialMachinery